Gestational diabetes is high blood sugar that appears for the first time during pregnancy, caused by placental hormones that deliberately make your body insulin-resistant — a demand your pancreas cannot always meet. The reassuring part is that blood sugar usually returns to normal shortly after delivery. The part that is not said often enough: that improvement is not the end of the story. It is the start of a follow-up window that lasts years, and its key is one simple test between four and twelve weeks postpartum — a test more than half of mothers never take.
In this article from Bakery 8 / مخبز ثمانية in Riyadh, Saudi Arabia, we explain what gestational diabetes actually is, why it is found by the calendar rather than by symptoms, and what the evidence says about the single most important medical appointment in a mother's life after delivery — the one nobody feels they need, precisely because everything seems fine again.
What Is Gestational Diabetes, and Why Isn't It Your Fault for Eating Dessert?
Let's start with the most painful misunderstanding attached to this diagnosis. Many mothers leave the clinic feeling guilty, as though the diagnosis were a penalty for a slice of cake in the fifth month. The physiology says something entirely different.
The Placenta Makes You Insulin-Resistant — On Purpose
During pregnancy, the placenta releases hormones whose job is to divert some glucose toward the baby. The medical reference StatPearls states that "human placental lactogen is the primary hormone associated with increased insulin resistance," adding that this same hormone "also increases insulin secretion and β-cell proliferation to regulate maternal hyperglycemia in normal pregnancies."
Put plainly: insulin resistance in pregnancy is not a malfunction. It is a designed setting. Every pregnant woman's body becomes less responsive to insulin, and her pancreas compensates by producing more. This happens in every healthy pregnancy.
So Where Does It Actually Go Wrong?
The problem is not the demand. It is the capacity to meet it. StatPearls describes the mechanism directly: "Maternal pancreatic β-cell dysfunction resulting in decreased insulin secretion is the primary mechanism that results in the inability to control maternal insulin resistance and increased glucose levels."
In other words, gestational diabetes is a stress test that pregnancy ran on your pancreas — and it revealed that the reserve was smaller than anyone knew. Hold onto that idea. It is exactly why postpartum follow-up matters so much.
Mayo Clinic lists the recognized risk factors: being overweight or obese, physical inactivity, having prediabetes, previous gestational diabetes, polycystic ovary syndrome, a family history of diabetes, and prior delivery of a baby weighing nine pounds or more. Notice that most of these are not daily behaviors. They are genetic and metabolic background that predated the pregnancy.
On scale: the CDC estimates that "every year, 5% to 9% of U.S. pregnancies are affected by gestational diabetes," while StatPearls cites a broader global figure from the International Diabetes Federation: "1 in 6 live births had a GDM diagnosis."
Why Is Gestational Diabetes Diagnosed by the Calendar, Not by Symptoms?
This is hard to absorb at first: you feel nothing. In most cases there is no extreme thirst, no unusual fatigue. The World Health Organization puts it plainly — gestational diabetes "is diagnosed through prenatal screening, rather than through reported symptoms."
So there is no feeling you can rely on, and no reason to postpone the test because you feel well. The test itself is the symptom.
When Is the Test Done?
The American Diabetes Association's 2026 criteria specify: "Screen for GDM at 24–28 wks gestation for those without known diabetes." That window is not arbitrary. It is when placenta-driven insulin resistance peaks, so any shortfall in capacity reveals itself.
If you have clear risk factors, your doctor may order earlier first-trimester testing to look for undiagnosed diabetes that existed before pregnancy — a completely different diagnosis from gestational diabetes.
The Two Approaches, and the Numbers Behind Them
There are two accepted pathways, and clinics differ in which they use:
- The one-step approach: a fasting 75-g oral glucose tolerance test. GDM is diagnosed when any of these values is exceeded — fasting 92 mg/dL, 1 hour 180 mg/dL, 2 hours 153 mg/dL.
- The two-step approach: begins with a non-fasting 50-g glucose load measured at one hour; if the threshold (130 to 140 mg/dL, depending on the center) is exceeded, a fasting 100-g OGTT follows, and GDM is diagnosed if at least two of four values meet or exceed 95, 180, 155 and 140 mg/dL.
One practical note: in the one-step approach a single exceeded value is enough to diagnose, while the two-step approach requires two. That difference alone explains much of what comes next.
Is "Wider Screening" Automatically Better? What a Trial of 23,792 Pregnancies Found
Here is a lesson in reading evidence that goes well beyond gestational diabetes. In 2021 the New England Journal of Medicine published a pragmatic randomized trial (ScreenR2GDM) that assigned 23,792 pregnancies to one approach or the other.
The first result was predictable: the one-step approach diagnosed nearly twice as many cases — 16.5% versus 8.5% (unadjusted relative risk 1.94; 97.5% CI, 1.79 to 2.11).
The second result was the surprise. The outcomes that actually matter did not move:
- Large for gestational age: 8.9% versus 9.2% (RR 0.95; 97.5% CI, 0.87 to 1.05).
- Perinatal composite outcome: 3.1% versus 3.0% (RR 1.04; 0.88 to 1.23).
- Gestational hypertension or preeclampsia: 13.6% versus 13.5% (RR 1.00; 0.93 to 1.08).
- Primary cesarean delivery: 24.0% versus 24.6% (RR 0.98; 0.93 to 1.02).
The lesson is not "screening is useless" — that would be a dangerous misreading. The lesson is that a test's value is measured by what it changes in outcomes, not by how many diagnoses it produces. Doubling the number of labels did not produce a single healthier mother or baby in this trial.
Meanwhile, treating the women who are diagnosed does make a difference. StatPearls notes that "proper control of maternal glucose levels significantly reduces GDM risks, including macrosomia and neonatal hypoglycemia," and that "the risk of preeclampsia decreases from 18% to 12% with treatment." So: screening is necessary, treatment helps, and the live debate is about which screening method — not about whether to screen at all.
The Spine: The Pregnancy Ends, the Risk Does Not End With It
This is the idea the article was written for.
The Good News That Stops People From Following Up
Mayo Clinic writes that "for most people who have gestational diabetes, blood sugar goes back to its usual level soon after a baby is born." That sentence is entirely true, and it is also the number one reason follow-up stops. The numbers normalized, the baby arrived, life turned upside down. Who is thinking about a glucose test right now?
But Mayo finishes the thought: "If you've had gestational diabetes, you have a higher risk of getting type 2 diabetes."
The Number: Nine and a Half Times
A systematic review and meta-analysis published in the BMJ in 2020 pooled 20 observational studies covering 1,332,373 individuals (including 67,956 women with GDM). The pooled relative risk of developing type 2 diabetes was 9.51 (95% CI, 7.14 to 12.67; P<0.001) compared with women who had a normoglycemic pregnancy.
More important than the bare figure is how it accumulates. In studies following women one to five years after delivery, pooled cumulative incidence was about 9.22% (7.19% to 11.26%), rising to 16.15% (15.83% to 16.47%) in studies with more than ten years of follow-up. The risk does not arrive all at once. It creeps.
Or in the CDC's simpler phrasing: "About half of women with gestational diabetes go on to develop type 2 diabetes."
In fairness, the BMJ authors listed limits on their own work: studies not published in English were excluded; missing data prevented analysis of family history of diabetes or parity; ethnic categorization was broad enough to limit subgroup analysis; and the absence of individual patient data reduced the precision of timing analysis.
The Test Most Mothers Miss
This is why there is a clear, time-bound recommendation. ADA Recommendation 15.25 (evidence grade B) states: "Screen individuals with a recent history of GDM at 4–12 weeks postpartum, using the 75-g oral glucose tolerance test and clinically appropriate nonpregnancy diagnostic criteria."
And follow-up does not stop at one normal result. Recommendation 15.28 (also grade B) states that individuals with prior GDM "should have lifelong screening for the development of type 2 diabetes or prediabetes every 1–3 years."
One technical point matters here: the recommended test is specifically the 75-g tolerance test, not simply a fasting glucose. Post-meal glucose handling typically deteriorates before fasting glucose rises — the same principle we covered at length in our article on prediabetes.
Why Is This Visit Missed in Saudi Arabia Specifically?
Here we found a recent Saudi study worth reading carefully. Published in Healthcare on 17 August 2026, it surveyed 316 parous women in Riyadh, 88 of whom reported a prior history of gestational diabetes.
The first finding is quietly shocking: having had gestational diabetes did not raise awareness of future diabetes risk at all — 71.6% versus 66.2% full awareness between the groups, a difference that was not statistically significant (P = 0.361). In other words, the diagnosis by itself taught nobody anything.
Postpartum screening was reported by 52.3% of women with prior GDM (versus 34.2% of those without). Roughly half of the highest-risk group never took the test.
But the genuinely useful part is what changed the picture:
- Women given a scheduled follow-up appointment reached 89.5% awareness, versus 50.0% for those who received no counseling.
- Among women with high awareness, 66.7% were screened, versus only 16.0% of those with low awareness.
The authors' conclusion was direct: "A prior history of GDM did not translate into higher self-reported awareness of future T2DM risk," while structured postpartum counseling was independently associated with greater screening adherence.
The practical lesson for any mother reading this: the gap is not biological. It is an appointment. The single request worth making before you leave the hospital is, "I want a booked appointment for a glucose test in six weeks." A written date beats a good intention.
What Actually Lowers the Risk After Delivery?
The good news is that this is one of the clearest situations in which we have real data on what works.
Lifestyle — and a Medication That Performs Unusually Well Here
An analysis of the Diabetes Prevention Program published in The Journal of Clinical Endocrinology & Metabolism in 2008 compared 350 women with a history of GDM against 1,416 parous women without that history. Among those on placebo, "women with a history of GDM randomized to placebo had a crude incidence rate of diabetes 71% higher than that of women without such a history."
Then came the striking result:
- Intensive lifestyle intervention reduced diabetes incidence by roughly 50% in the GDM-history group, and by 49% in parous women without GDM — effective in both.
- Metformin reduced incidence by roughly 50% in the GDM-history group, but by only 14% in women without prior gestational diabetes.
That is a large, group-specific difference: a drug that looks modest in the general population approaches lifestyle-level effectiveness in this particular group. This is a purely medical decision to make with your doctor, not something to buy on your own initiative — but it is an excellent reason to attend that appointment rather than skip it.
Breastfeeding
ADA Recommendation 15.27 (evidence grade A) states that "breastfeeding efforts are recommended for all individuals with diabetes," and that breastfeeding is recommended for those with a history of GDM "for multiple benefits, including a reduced risk for type 2 diabetes later in life."
A Risk-Factor Map From 2026
On 16 June 2026, Diabetology & Metabolic Syndrome published an umbrella review pooling 12 systematic reviews and meta-analyses covering "over 400 primary studies and more than 6 million participants." What it mapped:
- Insulin use during pregnancy: odds ratios ranging from 3.23 to 4.35 — meaning that needing insulin in pregnancy signals a larger β-cell shortfall, not merely "a more severe case."
- HbA1c was the strongest glycemic marker, with odds ratios up to 6.62.
- Pre-pregnancy and postpartum BMI, family history of diabetes, and recurrent GDM in a later pregnancy were all recurring factors.
- Lactation was protective, with relative risks ranging from 0.42 to 0.77.
And in fairness, the authors placed brakes on their own work. They could not convert the differing effect measures "into a common metric" reliably, lactation definitions were not standardized, and BMI was not uniformly categorized. Under AMSTAR 2, nine reviews were rated moderate quality and three low, and "no SRMA was rated as high quality." Read this map as general direction, not as precise numbers that apply to you personally.
Said Plainly: No Bread Treats Gestational Diabetes — and Pregnancy Is Not the Time for Keto
We are a keto, sugar-free bakery, and it would be very easy for a bakery like ours to sell itself to every woman searching for an answer to gestational diabetes. We will not do that, and here are the reasons in writing.
First: nutrition in gestational diabetes is a medical plan built with your doctor and dietitian, not a product list. ADA Recommendation 15.13 calls for "a balance of macronutrients including nutrient-dense fruits, vegetables, legumes, whole grains, and healthy fats."
Second, and more important: pregnancy is not the time for keto. The same standards specify that "the recommended dietary reference intake for all pregnant people is a minimum of 175 g of carbohydrate (∼35% of a 2,000-calorie diet), a minimum of 71 g of protein, and 28 g of fiber." That figure is fundamentally incompatible with any ketogenic regimen. Our earlier article on ketones and ketosis explains why ketones are a subject to handle carefully in the first place.
And for complete accuracy, the scientific basis for that number is less settled than it looks. A 2021 paper in Diabetes Care reviewed the question and concluded that "the evidence behind these guidelines is conflicting and inconsistent," and that "there is insufficient evidence to support current recommendations on necessary carbohydrate intake and avoidance of ketones." We mention this because we do not hide what weakens our own case — but the practical conclusion is unchanged: when the evidence is unsettled during pregnancy, the decision belongs to your doctor, not to an article and not to a bakery.
So what stays honest? One thing only: displacement. If your nutrition plan — after delivery, or with your dietitian's approval during it — allows a specific amount of carbohydrate, then choosing an almond-flour product instead of white flour is a substitution inside that amount. It is not a treatment for it and not a way around it. Browse our bread or granola in that spirit only. Any larger promise would be a lie.
Who Should Be Most Careful, and When to Consult Your Doctor
This section is not an extra detail. It is the most practically important part:
- Every pregnant woman: do not change your diet or any medication based on an article — including this one. Pregnancy nutrition is managed under direct supervision.
- If you have been diagnosed with GDM: Recommendation 15.15 (evidence grade A) states that "insulin is the preferred medication for treating hyperglycemia in GDM. Metformin and glyburide, individually or in combination, should not be used as first-line agents, as both cross the placenta to the fetus." This deserves attention from anyone who assumes a tablet is "gentler" than an injection. If you use insulin, see our article on correct injection technique.
- After delivery: ask for a glucose test appointment between weeks four and twelve, and do not cancel it because you feel fine — feeling is not a test, as we have seen.
- If you have an older history of GDM: even years later, screening every one to three years remains a lifelong recommendation.
- If you have PCOS, a family history, or previously delivered a high-birth-weight baby: discuss with your doctor whether earlier first-trimester screening is appropriate for you.
This article is educational only and is not a substitute for consulting your doctor or dietitian. Do not start, stop, or adjust any medication or diet during or after pregnancy on your own.
Frequently Asked Questions
Did I cause my gestational diabetes by eating sweets?
No. Gestational diabetes develops when pancreatic β-cells cannot keep pace with the insulin resistance that placental hormones create in every pregnancy. The risk factors Mayo Clinic lists — family history, PCOS, prediabetes, previous gestational diabetes — mostly predate your pregnancy. Diet is part of management, not part of blame.
When should I be tested for gestational diabetes?
Standard screening is at 24 to 28 weeks of pregnancy for those without known diabetes, per the ADA's 2026 criteria. If you have clear risk factors, your doctor may order earlier first-trimester testing to look for undiagnosed pre-pregnancy diabetes — a different condition from gestational diabetes.
My gestational diabetes went away after delivery. Is it over?
No. Blood sugar returning to normal is expected, but the 2020 BMJ meta-analysis found a relative risk of type 2 diabetes of 9.51, with cumulative incidence rising from about 9.22% in the first five years to 16.15% beyond ten years. Postpartum testing and periodic follow-up remain essential.
Which test is needed after delivery, and when?
A 75-g oral glucose tolerance test between four and twelve weeks postpartum, per ADA Recommendation 15.25. If the result is normal, screening continues every one to three years for life under Recommendation 15.28. A fasting glucose alone is not an adequate substitute for the tolerance test here.
Will a keto diet help me manage gestational diabetes?
No, and this is not our opinion but what the guidelines require: the recommended dietary reference intake for all pregnant people is a minimum of 175 g of carbohydrate per day, a figure incompatible with any ketogenic regimen. A pregnancy nutrition plan is set exclusively with your doctor and dietitian.
Does breastfeeding really lower my risk?
The evidence points that way. ADA Recommendation 15.27 states that breastfeeding is recommended for those with a history of GDM "for multiple benefits, including a reduced risk for type 2 diabetes later in life," and the 2026 umbrella review found protective relative risks ranging from 0.42 to 0.77 — while noting that lactation definitions were not standardized across studies.
Conclusion
Gestational diabetes is not a punishment and not a personal failure. It is a stress test that revealed something important about your body years before you would otherwise have needed to know it. The real value of that information is not realized during the pregnancy — it is realized in the appointment you book six weeks after delivery, and in the test you repeat every one to three years thereafter.
At Bakery 8 / مخبز ثمانية we are here to make only the daily part easier: sugar-free, almond-flour alternatives that fit inside a nutrition plan a professional sets — never a replacement for one. Browse our bread and cakes if that suits your plan.
References
- American Diabetes Association. "15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes." Diabetes Care (recommendations 15.13, 15.15, 15.25, 15.27, 15.28).
- American Diabetes Association. "Recommendations for Diagnosis and Classification of Diabetes — 2026" (GDM screening at 24–28 weeks; one-step and two-step thresholds; postpartum 75-g OGTT at 4–12 weeks).
- Vounzoulaki E, et al. "Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis." BMJ 2020;369:m1361.
- "Global evidence on risk factors for the progression of gestational diabetes to type 2 diabetes: an umbrella review of systematic reviews and meta-analyses." Diabetology & Metabolic Syndrome 2026;18:184 (16 June 2026).
- Hillier TA, et al. "A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening" (ScreenR2GDM). New England Journal of Medicine 2021.
- Ratner RE, et al. "Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions." The Journal of Clinical Endocrinology & Metabolism 2008;93(12):4774.
- "Awareness of Future Type 2 Diabetes Risk Among Parous Women With and Without Self-Reported Prior Gestational Diabetes in Riyadh, Saudi Arabia: A Questionnaire-Based Cross-Sectional Survey." Healthcare (Basel) 2026;14(16) (17 August 2026).
- StatPearls. "Gestational Diabetes." NCBI Bookshelf, National Library of Medicine.
- Mayo Clinic. "Gestational diabetes — Symptoms and causes."
- Centers for Disease Control and Prevention (CDC). "About Gestational Diabetes."
- World Health Organization (WHO). "Diabetes — Fact sheet."
- "Ketones in Pregnancy: Why Is It Considered Necessary to Avoid Them and What Is the Evidence Behind Their Perceived Risk?" Diabetes Care 2021;44(1):280.
Related keywords: gestational diabetes, gestational diabetes screening, postpartum glucose test, 75-g oral glucose tolerance test, gestational diabetes and type 2 diabetes, 24 to 28 weeks, postpartum follow-up, insulin resistance in pregnancy.